Efficacy and Safety of Udenafil for the Treatment of Pulmonary Arterial Hypertension: a Placebo-controlled, Double-blind, Phase IIb Clinical Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Udenafil for the Treatment of Pulmonary Arterial Hypertension: a Placebo-controlled, Double-blind, Phase IIb Clinical Trial

Published:2019-08 Issue:8 Volume:41 Page:1499-1507
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Chang Hyuk-Jae,Song Shinjeong,Chang Sung-A.,Kim Hyung-Kwan,Jung Hae-Ok,Choi Jung-Hyun,Lee Jae Seung,Kim Kye-Hun,Jeong Jin-Ok,Lee Ju Hee,Kim Duk-Kyung

Funder

Dong-A Pharmaceutical Company

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference19 articles.

1. Development and pathology of pulmonary hypertension;Tuder;J Am Coll Cardiol,2009

2. Pulmonary arterial hypertension;Chin;J Am Coll Cardiol,2008

3. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension;Galiè;Eur Heart J,2009

4. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial;Zhao;Eur Urol,2011

5. Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial;Park;J Sex Med,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic approaches and clinical application of representative small-molecule inhibitors of phosphodiesterase;European Journal of Medicinal Chemistry;2024-11

2. New and Emerging Therapeutic Drugs for the Treatment of Pulmonary Arterial Hypertension: A Systematic Review;Cureus;2024-08-29

3. Emerging pharmacotherapies for the treatment of pulmonary arterial hypertension;Expert Opinion on Investigational Drugs;2023-10-30

4. Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives;Pharmaceuticals;2023-09-06

5. Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?;Drugs;2023-04-05